ShareValue.ai

ShareValue scores for MOREPENLAB.NSE: Valuation 68, Quality 28, Growth 60, Health 49.

MOREPENLAB.NSE
NSE

Morepen Laboratories Limited

₹61.19(+0.67%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 19%
Valuation
68
Fair Value
Price vs Value
Quality
28
Weak
Business Strength
Growth
60
Moderate
Revenue & Earnings
Health
49
Moderate
Financial Stability
Momentum
68
Bullish
Price Trend

Company Details

About

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Score Analysis

AI Investment Thesis

Data as of:Jul 9, 2026
|
Last calculated:Jul 9, 2026